What analyst predict for Accelerate Diagnostics NASDAQ:AXDX ?
Accelerate Diagnostics NYSE:AXDX headquartered in Tucson, Arizona, United States is reporting their earnings on 05/09/2018 before the bell. Street forecast for the quarter ending March 2018 is $-0.31.
According to stock market daily analyst this is Lower then same time previous year. Accelerate Diagnostics reported EPS for the same quarter last year was $-0.27.
Overview of Accelerate Diagnostics NYSE:AXDX
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Established in 1987, the company began research activity for microbiology solutions in 2004 and relaunched in 2012 as Accelerate Diagnostics, Inc. to develop and commercialize its first diagnostic platform.
The cornerstone of our ability to provide breakthrough diagnostic solutions hinges on developing technologies that address the needs of clinicians. We work with healthcare partners across the globe to ensure our innovations lead to critical answers that drive improved treatment options for patients.
|% Change from 52 Week Low|
|% Change from 52 Week High|